reuterin
Biologicalexperimental
Reuterin (3-hydroxypropionaldehyde) is the organic compound with the formula HOCH2CH2CHO. It is a bifunctional molecule, containing both a hydroxy and aldehyde functional groups. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2014 (NCT02734446)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaReuterin ↗
Also known as
- 3-hpa
- 3-hydroxypropionaldehyde
- beta-hydroxypropionaldehyde
- reuterin
- reuterin
- reuterin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02734446 | Phase 3 | Apr 1, 2014 | University of Campania Luigi Vanvitelli |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Campania Luigi Vanvitelli | Academic/Hospital | 1 | 1 | 1 | 2014 |
1 organizations
Page 1 / 1